Chapter 4: A closer look at the glomerulus and sodium glucose transporter
Experts review glomerular pathophysiology and landmark studies showing improved clinical outcomes in chronic kidney disease. The discussion includes the mechanism of action of sodium glucose cotransporter-2 (SGLT2) inhibitor treatment within the kidney, as well as potential risks.